NCT00013533View on ClinicalTrials.gov

Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 14, 2001

Primary Completion Date

March 1, 2008

Study Completion Date

May 7, 2015

Conditions
Hodgkin LymphomaLymphocytic LeukemiaMixed Cell LeukemiaMyelodysplastic SyndromeNon Hodgkin's LymphomaCMLALLAMLLymphoma
Interventions
PROCEDURE

Stem cell transplantation

\>3 x 106/kg CD34+ stem cells by IV infusion

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00013533 - Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies | Biotech Hunter | Biotech Hunter